News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Evotec AG (EVTG.F) Partners With Haplogen to Develop Drugs for Infectious Diseases


11/15/2012 7:43:25 AM

HAMBURG, Germany and VIENNA, Austria, Nov. 15, 2012 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) and Haplogen GmbH have signed a collaboration agreement to discover and develop small molecules against viral infectious diseases.

Read at GlobeNewswire

comments powered by Disqus
Evotec AG
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES